This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Anti-Viral Technologies, LLC. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Ronnea Murdock: Innovator in Antiviral Technologies
Introduction
Ronnea Murdock is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of antiviral treatments through his innovative research and development. His work focuses on methods and compositions that utilize synthetic lysine analogs and mimetics to combat viral infections.
Latest Patents
Ronnea Murdock holds a patent for "Methods and compositions for the antiviral use of synthetic lysine analogs and mimetics." This patent outlines a method for the treatment, prevention, or reduction of one-time or recurring viral outbreaks. It also addresses the suppression of chronic viral infections. The method involves administering a synthetic lysine analog or mimetic that antagonizes or competes with an amino acid or other biological agents required by viruses to replicate or spread. The composition aims to treat, prevent, or reduce viral infections effectively.
Career Highlights
Ronnea Murdock is associated with Anti-Viral Technologies, LLC, where he continues to advance his research in antiviral solutions. His dedication to innovation in this field has positioned him as a key figure in developing effective treatments for viral infections.
Collaborations
Some of his notable coworkers include W Paul Stewart and Frank Murdock. Their collaboration has contributed to the success of the projects undertaken at Anti-Viral Technologies, LLC.
Conclusion
Ronnea Murdock's work in antiviral technologies exemplifies the impact of innovative thinking in addressing public health challenges. His contributions through patents and collaborations continue to pave the way for advancements in the treatment of viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile